Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Virax Biolabs Group Limited (VRAX)

Virax Biolabs Group Limited (VRAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,272
  • Shares Outstanding, K 3,233
  • Annual Sales, $ 160 K
  • Annual Income, $ -6,730 K
  • EBIT $ 0 M
  • EBITDA $ -6 M
  • 60-Month Beta 1.94
  • Price/Sales 38.96
  • Price/Cash Flow N/A
  • Price/Book 0.94

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7600 +14.20%
on 11/18/24
3.6200 -44.48%
on 10/23/24
+0.3300 (+19.64%)
since 10/22/24
3-Month
1.4600 +37.67%
on 10/18/24
7.6300 -73.66%
on 08/28/24
-3.1700 (-61.20%)
since 08/22/24
52-Week
0.6000 +235.00%
on 05/03/24
9.0000 -77.67%
on 08/19/24
-0.4400 (-17.99%)
since 11/22/23

Most Recent Stories

More News
Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

/PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune...

VRAX : 2.0100 (+3.61%)
Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

/PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune...

VRAX : 2.0100 (+3.61%)
Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

/PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune...

VRAX : 2.0100 (+3.61%)
Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

/PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune...

VRAX : 2.0100 (+3.61%)
Virax Biolabs' CEO James Foster Issues Letter to Shareholders

/PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune...

VRAX : 2.0100 (+3.61%)
Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

/PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune...

VRAX : 2.0100 (+3.61%)
Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

/PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotech company focused on the detection of immune...

VRAX : 2.0100 (+3.61%)
Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

/PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention,...

VRAX : 2.0100 (+3.61%)
Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

/PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention,...

VRAX : 2.0100 (+3.61%)
Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

/PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the prevention, detection,...

VRAX : 2.0100 (+3.61%)

Business Summary

Virax Biolabs Group Limited is a biotechnology company focused on the prevention, detection, and diagnosis of viral diseases as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus. Virax Biolabs Group Limited is based in London, United Kingdom.

See More

Key Turning Points

3rd Resistance Point 2.2900
2nd Resistance Point 2.2000
1st Resistance Point 2.1000
Last Price 2.0100
1st Support Level 1.9100
2nd Support Level 1.8200
3rd Support Level 1.7200

See More

52-Week High 9.0000
Fibonacci 61.8% 5.7900
Fibonacci 50% 4.8000
Fibonacci 38.2% 3.8100
Last Price 2.0100
52-Week Low 0.6000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar